Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| microglial cell | 13 studies | 44% ± 15% | |
| epithelial cell | 5 studies | 31% ± 9% | |
| goblet cell | 4 studies | 16% ± 1% | |
| oligodendrocyte | 4 studies | 21% ± 4% | |
| endothelial cell | 3 studies | 17% ± 0% | |
| myeloid cell | 3 studies | 20% ± 2% | |
| GABAergic neuron | 3 studies | 29% ± 4% | |
| glutamatergic neuron | 3 studies | 35% ± 5% | |
| macrophage | 3 studies | 24% ± 7% | |
| astrocyte | 3 studies | 22% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 6 studies | 27% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 1633.89 | 459 / 459 | 100% | 33.87 | 1114 / 1118 |
| esophagus | 100% | 1643.48 | 1445 / 1445 | 99% | 23.03 | 182 / 183 |
| brain | 100% | 1125.56 | 2630 / 2642 | 100% | 28.66 | 703 / 705 |
| lung | 99% | 1217.85 | 575 / 578 | 99% | 16.84 | 1147 / 1155 |
| pancreas | 100% | 814.81 | 327 / 328 | 99% | 20.13 | 176 / 178 |
| skin | 100% | 1713.45 | 1808 / 1809 | 99% | 35.18 | 465 / 472 |
| prostate | 100% | 1437.75 | 245 / 245 | 98% | 14.47 | 494 / 502 |
| intestine | 100% | 2063.87 | 965 / 966 | 98% | 19.09 | 519 / 527 |
| uterus | 100% | 1661.43 | 170 / 170 | 98% | 17.41 | 449 / 459 |
| stomach | 100% | 1289.25 | 359 / 359 | 98% | 19.40 | 279 / 286 |
| bladder | 100% | 1476.90 | 21 / 21 | 96% | 15.03 | 485 / 504 |
| kidney | 100% | 1007.75 | 89 / 89 | 96% | 16.12 | 866 / 901 |
| thymus | 100% | 1366.66 | 653 / 653 | 96% | 14.01 | 581 / 605 |
| ovary | 100% | 1212.89 | 180 / 180 | 95% | 10.24 | 410 / 430 |
| liver | 100% | 1605.62 | 226 / 226 | 95% | 14.15 | 387 / 406 |
| adrenal gland | 100% | 1236.97 | 258 / 258 | 90% | 10.12 | 207 / 230 |
| adipose | 100% | 1387.33 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1314.29 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 67.47 | 80 / 80 |
| ureter | 0% | 0 | 0 / 0 | 100% | 9.66 | 1 / 1 |
| muscle | 100% | 1842.14 | 802 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 602.27 | 240 / 241 | 0% | 0 | 0 / 0 |
| heart | 97% | 1090.21 | 832 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 11.40 | 43 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 62% | 4.17 | 18 / 29 |
| peripheral blood | 21% | 132.45 | 194 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006952 | Biological process | defense response |
| GO_0016567 | Biological process | protein ubiquitination |
| GO_0050868 | Biological process | negative regulation of T cell activation |
| GO_0035556 | Biological process | intracellular signal transduction |
| GO_0046854 | Biological process | phosphatidylinositol phosphate biosynthetic process |
| GO_0040008 | Biological process | regulation of growth |
| GO_0007259 | Biological process | cell surface receptor signaling pathway via JAK-STAT |
| GO_0009968 | Biological process | negative regulation of signal transduction |
| GO_0010498 | Biological process | proteasomal protein catabolic process |
| GO_0001772 | Cellular component | immunological synapse |
| GO_0005942 | Cellular component | phosphatidylinositol 3-kinase complex |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005515 | Molecular function | protein binding |
| GO_0046935 | Molecular function | 1-phosphatidylinositol-3-kinase regulator activity |
| Gene name | SOCS6 |
| Protein name | Suppressor of cytokine signaling 6 Suppressor of cytokine signaling 6 (SOCS-6) (Cytokine-inducible SH2 protein 4) (CIS-4) (Suppressor of cytokine signaling 4) (SOCS-4) |
| Synonyms | CIS4 SOCS4 |
| Description | FUNCTION: SOCS family proteins form part of a classical negative feedback system that regulates cytokine signal transduction. May be a substrate recognition component of a SCF-like ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins (By similarity). Regulates KIT degradation by ubiquitination of the tyrosine-phosphorylated receptor. . |
| Accessions | J3KTM7 ENST00000582322.1 ENST00000397942.4 ENST00000578377.1 O14544 |